Related Experiment Video
Updated: May 16, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized
Francesco Salerno1, Roberta J Navickis, Mahlon M Wilkes
1Dipartimento di Medicina Interna, Università degli Studi di Milano, Policlinico IRCCS San Donato, Milano, Italy. francesco.salerno@unimi.it
Background & Aims:
Renal impairment increases mortality among patients with spontaneous bacterial peritonitis (SBP), despite administration of non-nephrotoxic antibiotics. Albumin infusion has been reported to reduce renal impairment and mortality in patients with SBP. We performed a meta-analysis of randomized controlled trials (RCTs) to quantify the effect of albumin infusion on renal impairment and mortality in patients with SBP.
Methods:
We searched MEDLINE, EMBASE, the Cochrane Library, and ClinicalTrials.gov for RCTs that evaluated albumin treatment for patients with SBP; we also performed searches by additional methods. Four trials of 288 total patients were included in our analysis. Data were quantitatively combined under a fixed-effects model.
Results:
We found no evidence of statistically significant heterogeneity or publication bias among the studies analyzed. Albumin was compared with no albumin in 3 trials and with artificial colloid in 1 trial. All patients received antibiotics. The incidence of renal impairment in control groups was 44 of 144 (30.6%), compared with 12 of 144 (8.3%) in groups given albumin. The pooled odds ratio for a reduction in renal impairment after albumin infusion was 0.21 (95% confidence interval, 0.11-0.42). Odds ratios for renal impairment after albumin therapy ranged from 0.19-0.30 among the individual studies. Mortality among controls was 51 of 144 (35.4%), compared with 23 of 144 (16.0%) among patients who received albumin. The pooled odds ratio for decreased mortality after infusion of albumin was 0.34 (95% confidence interval, 0.19-0.60). Odds ratios for mortality in individual RCTs ranged from 0.16-0.55.
Conclusions:
In a meta-analysis of 4 RCTs (288 patients), albumin infusion prevented renal impairment and reduced mortality among patients with SBP.
Insights
Albumin infusion significantly reduces renal impairment and mortality in patients with spontaneous bacterial peritonitis (SBP). This meta-analysis of randomized controlled trials confirms albumin
Area of Science:
- Hepatology
- Nephrology
- Critical Care Medicine
Background:
- Renal impairment is a significant predictor of mortality in patients with spontaneous bacterial peritonitis (SBP).
- Standard antibiotic treatment for SBP does not adequately address the risk of renal complications.
- Albumin infusion has shown promise in mitigating renal impairment and improving survival in SBP patients.
Purpose of the Study:
- To conduct a meta-analysis of randomized controlled trials (RCTs).
- To quantify the impact of albumin infusion on renal impairment and mortality in SBP patients.
Main Methods:
- Searched major medical databases (MEDLINE, EMBASE, Cochrane Library, ClinicalTrials.gov) for relevant RCTs.
- Included four RCTs with a total of 288 patients.
- Performed a fixed-effects model meta-analysis to combine data.
Main Results:
- No significant heterogeneity or publication bias was detected among the included studies.
- Albumin infusion reduced the incidence of renal impairment from 30.6% to 8.3% (OR, 0.21; 95% CI, 0.11-0.42).
- Mortality decreased from 35.4% in control groups to 16.0% in groups receiving albumin (OR, 0.34; 95% CI, 0.19-0.60).
Conclusions:
- Albumin infusion is effective in preventing renal impairment in SBP patients.
- Albumin infusion significantly reduces mortality associated with SBP.
- The findings support the use of albumin infusion as an adjunct therapy for SBP.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Peritoneal Dialysis III: Nursing Management
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations: